Does semaglutide really contribute to vision loss?
As the popularity of GLP-1 medications used for weight loss continues to increase, more research is being done to further examine potential side effects of these medications. One such side effect is possible eye issues and vision loss, for which there is currently a great deal of conflicting information. Some studies link GLP-1 use to an increased risk for ocular diseases such as nonarteritic anterior ischemic optic neuropathy (NAION), diabetic retinopathy, papillitis, and optic nerve disorders. A new study reports that using semaglutide is not associated with an increased risk for eye disorders or diabetic retinopathy. While this new study found a connection between semaglutide use and NAION, researchers say that the current evidence is insufficient to establish a definitive connection between the two.